Access cutting-edge leukemia or lymphoma treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access leukemia or lymphoma specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related leukemia or lymphoma treatment provided free
This phase III trial compares the effect of adding levocarnitine to standard chemotherapy versus (vs.) standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care chemotherapy for the treatment of acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), and mixed phenotype acute leukemia (MPAL). However, in adolescent and young adults (AYA) ages 15-39 years, liver toxicity from asparaginase is common and often pr
Sponsor: Children's Oncology Group
Check if you qualify for this leukemia or lymphoma clinical trial in Birmingham, AL
If you're searching for leukemia or lymphoma treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced leukemia or lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.